ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Oruka Therapeutics Inc

Oruka Therapeutics Inc (ORKA)

11.44
-0.75
(-6.15%)
終了 1月28日 6:00AM
11.47
0.03
(0.26%)
取引時間後: 9:59AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
11.44
買値
10.11
売値
15.00
出来高
219,566
11.32 日の範囲 12.27
11.47 52 週間の範囲 31.13
時価総額
前日終値
12.19
始値
12.16
最終取引時間
財務取引量
US$ 2,556,191
VWAP
11.642
平均取引量 (3 か月)
306,800
発行済株式数
34,998,550
配当利回り
-
PER
-75.21
1 株当たり利益 (EPS)
-0.15
歳入
-
純利益
-5.34M

Oruka Therapeutics Inc について

ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome ... ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. 詳細を表示

セクター
In Vitro,in Vivo Diagnostics
業界
In Vitro,in Vivo Diagnostics
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Oruka Therapeutics Inc is listed in the In Vitro,in Vivo Diagnostics sector of the ナスダック市場 with ticker ORKA. The last closing price for Oruka Therapeutics was US$12.19. Over the last year, Oruka Therapeutics shares have traded in a share price range of US$ 11.47 to US$ 31.13.

Oruka Therapeutics currently has 34,998,550 shares in issue. The market capitalisation of Oruka Therapeutics is US$426.63 million. Oruka Therapeutics has a price to earnings ratio (PE ratio) of -75.21.

ORKA 最新ニュース

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody

Pharmacokinetic and safety data from healthy volunteers anticipated in the second half of 2025 On track to initiate a proof-of-concept study in psoriasis in the second half of 2025, with initial...

Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)

MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-1.56-121313.6211.4745576512.69329215CS
4-7.52-39.662447257418.9621.31511.4732345315.13985668CS
12-16.12-58.490566037727.5628.2511.4730680019.81094894CS
26-14.06-55.13725490225.531.1311.4720428421.07868285CS
52-14.06-55.13725490225.531.1311.4720428421.07868285CS
156-14.06-55.13725490225.531.1311.4720428421.07868285CS
260-14.06-55.13725490225.531.1311.4720428421.07868285CS

ORKA - Frequently Asked Questions (FAQ)

What is the current Oruka Therapeutics share price?
The current share price of Oruka Therapeutics is US$ 11.44
How many Oruka Therapeutics shares are in issue?
Oruka Therapeutics has 34,998,550 shares in issue
What is the market cap of Oruka Therapeutics?
The market capitalisation of Oruka Therapeutics is USD 426.63M
What is the 1 year trading range for Oruka Therapeutics share price?
Oruka Therapeutics has traded in the range of US$ 11.47 to US$ 31.13 during the past year
What is the PE ratio of Oruka Therapeutics?
The price to earnings ratio of Oruka Therapeutics is -75.21
What is the reporting currency for Oruka Therapeutics?
Oruka Therapeutics reports financial results in USD
What is the latest annual profit for Oruka Therapeutics?
The latest annual profit of Oruka Therapeutics is USD -5.34M
What is the registered address of Oruka Therapeutics?
The registered address for Oruka Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Oruka Therapeutics website address?
The website address for Oruka Therapeutics is www.orukatx.com
Which industry sector does Oruka Therapeutics operate in?
Oruka Therapeutics operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
JGAurora Mobile Ltd
US$ 14.56
(142.18%)
38.51M
AKROAkero Therapeutics Inc
US$ 51.77
(97.75%)
15.06M
ORKTOrangeKloud Technology Inc
US$ 1.30
(88.41%)
62.83M
HWHHWH International Inc
US$ 0.49
(70.32%)
393.88M
GITSGlobal Interactive Technologies Inc
US$ 3.0424
(56.34%)
4.71M
ALLKAllakos Inc
US$ 0.2402
(-80.15%)
51.22M
NXUNXU Inc
US$ 0.2513
(-59.20%)
14.06M
VERUVeru Inc
US$ 0.6351
(-47.51%)
43.51M
WOKWORK Medical Technology Group Ltd
US$ 2.53
(-47.51%)
862.6k
NBISNebius Group NV
US$ 26.08
(-37.44%)
43.58M
NVDANVIDIA Corporation
US$ 118.42
(-16.97%)
798.95M
HWHHWH International Inc
US$ 0.49
(70.32%)
393.89M
HOLOMicroCloud Hologram Inc
US$ 1.67
(7.74%)
201.59M
ONCOOnconetix Inc
US$ 0.66
(37.50%)
185M
RGTIRigetti Computing Inc
US$ 12.44
(-5.76%)
123.5M

最近閲覧した銘柄

Delayed Upgrade Clock